Cancer Research
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Activation of canonical BMP4-SMAD7 signaling suppresses breast cancer metastasis.
80:1304-1315.
2020
-
Eph receptors in the immune-suppressive tumor microenvironment
2020
-
Frizzled-7 is required for Wnt signalling in gastric tumors with and without Apc mutations.
79:970-981.
2019
-
Inflammasome adaptor ASC suppresses apoptosis of gastric cancer cells by an IL18-mediated inflammation-independent mechanism.
78:1293-1307.
2018
-
Tight junction protein claudin-2 promotes self-renewal of human colorectal cancer stem-like cells..
78:2925-2938.
2018
-
An Accessible Proteogenomics Informatics Resource for Cancer Researchers.
77:e43-e46.
2017
-
HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2 + Tumors.
77:2594-2606.
2017
-
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2.
77:1021-1034.
2017
-
Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model.
76:2277-2287.
2016
-
The Biodistribution and Immune Suppressive Effects of Breast Cancer-Derived Exosomes.
76:6816-6827.
2016
-
Correction: HOXB7, a Homeodomain Protein, Is Overexpressed in Breast Cancer and Confers Epithelial–Mesenchymal Transition.
75:2401-2401.
2015
-
Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation.
75:930-939.
2015
-
BMP4 Inhibits Breast Cancer Metastasis by Blocking Myeloid-Derived Suppressor Cell Activity.
74:5091-5102.
2014
-
Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.
74:3238-3247.
2014
-
Metabolic Vulnerabilities in Endometrial Cancer.
74:5832-5845.
2014
-
Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling.
74:5019-5031.
2014
-
Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment.
74:4470-4481.
2014
-
The Emerging Role of Immunosurveillance in Dictating Metastatic Spread in Breast Cancer.
73:5852-5857.
2013
-
SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer.
73:725-735.
2013
-
The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells.
73:1180-1189.
2013
-
Abstract P3-10-09: Peptide-based molecular targeting of inflammatory breast cancer..
72.
2012
-
Primary Tumor Hypoxia Recruits CD11b+/Ly6Cmed/Ly6G+Immune Suppressor Cells and Compromises NK Cell Cytotoxicity in the Premetastatic Niche.
72:3906-3911.
2012
-
Abstract 4316: Villin expression is frequently lost in colon cancers with microsatellite instability..
72.
2012
-
Abstract LB-308: Combination of CTx-0294945 a highly selective inhibitor of focal adhesion kinase with bevacizumab in pre-clinical models of breast cancer.
72.
2012
-
Vascular Normalization by Loss of Siah2 Results in Increased Chemotherapeutic Efficacy.
72:1694-1704.
2012
-
Cathepsin B Inhibition Limits Bone Metastasis in Breast Cancer.
72:1199-1209.
2012
-
Targeting of a conformationally exposed, tumor-specific epitope of EGFR as a strategy for cancer therapy.
72:2924-2930.
2012
-
MYB is essential for mammary tumorigenesis.
71:7029-7037.
2011
-
Abstract 1469: Mechanisms of oncostatin M (OSM)-mediated breast cancer metastasis to bone: Evidence for a role in osteoclastogenesis.
71.
2011
-
PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis.
71:3709-3719.
2011
-
Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer.
70:5901-5911.
2010
-
Altered Dynamics of Intestinal Cell Maturation in Apc1638N/+ Mice.
70:5348-5357.
2010
-
Correction: An A13 Repeat within the 3′-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression.
70:1275.2-1275.
2010
-
Apoptotic Sensitivity of Colon Cancer Cells to Histone Deacetylase Inhibitors Is Mediated by an Sp1/Sp3-Activated Transcriptional Program Involving Immediate-Early Gene Induction.
70:609-620.
2010
-
Correction: PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab.
69:9156-9156.
2009
-
Correction: Parathyroid Hormone-Related Protein Protects against Mammary Tumor Emergence and Is Associated with Monocyte Infiltration in Ductal Carcinoma In situ.
69:8832-8832.
2009
-
An A13 Repeat within the 3'-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression.
69:7811-7818.
2009
-
Parathyroid Hormone-Related Protein Protects against Mammary Tumor Emergence and Is Associated with Monocyte Infiltration in Ductal Carcinoma In situ.
69:7473-7479.
2009
-
The Receptor Tyrosine Kinase EPHB4 Has Tumor Suppressor Activities in Intestinal Tumorigenesis.
69:7430-7438.
2009
-
Transcriptional Output of the Salvador/Warts/Hippo Pathway Is Controlled in Distinct Fashions in Drosophila melanogaster and Mammalian Cell Lines.
69:6033-6041.
2009
-
Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells.
69:5996-6004.
2009
-
Correction: Article on Vaccination Reveals a Long Dominant CTL Epitope.
69:4553-4553.
2009
-
ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adduct forming treatments in HL-60 cells.
69.
2009
-
Bmp4 controls breast cancer metastasis by modulating CD11b(+)Gr1(+) cells in vivo.
69.
2009
-
The role of c-Myb in tumorigenesis and mammary gland development.
69.
2009
-
A Long, Naturally Presented Immunodominant Epitope from NY-ESO-1 Tumor Antigen: Implications for Cancer Vaccine Design.
69:1046-1054.
2009
-
Bone Morphogenetic Protein-7 Inhibits Telomerase Activity, Telomere Maintenance, and Cervical Tumor Growth.
68:9157-9166.
2008
-
Correction: Prediction of Response to Cetuximab.
68:6859-6859.
2008
-
Defective Claudin-7 Regulation by Tcf-4 and Sox-9 Disrupts the Polarity and Increases the Tumorigenicity of Colorectal Cancer Cells.
68:4258-4268.
2008
-
The Regulatory T Cell-Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells.
68:3001-3009.
2008
-
PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab.
68:1953-1961.
2008
-
TRAIL Induces Receptor-Interacting Protein 1–Dependent and Caspase-Dependent Necrosis-Like Cell Death under Acidic Extracellular Conditions.
67:218-226.
2007
-
HOXB7, a Homeodomain Protein, Is Overexpressed in Breast Cancer and Confers Epithelial-Mesenchymal Transition.
66:9527-9534.
2006
-
EPHB4 and Survival of Colorectal Cancer Patients.
66:8943-8948.
2006
-
Transduction of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand into Hematopoietic Cells Leads to Inhibition of Syngeneic Tumor Growth In vivo.
66:6304-6311.
2006
-
Doxorubicin-DNA Adducts Induce a Non-Topoisomerase II–Mediated Form of Cell Death.
66:4863-4871.
2006
-
Papillomavirus E2 Protein Induces Expression of the Matrix Metalloproteinase-9 via the Extracellular Signal-Regulated Kinase/Activator Protein-1 Signaling Pathway.
65:11613-11621.
2005
-
Mechanisms of Inactivation of the Receptor Tyrosine Kinase EPHB2 in Colorectal Tumors.
65:10170-10173.
2005
-
Apoptin Nuclear Accumulation Is Modulated by a CRM1-Recognized Nuclear Export Signal that Is Active in Normal but not in Tumor Cells.
65:7059-7064.
2005
-
Concurrent Binding of Anti-EphA3 Antibody and Ephrin-A5 Amplifies EphA3 Signaling and Downstream Responses: Potential as EphA3-Specific Tumor-Targeting Reagents.
65:6745-6754.
2005
-
OncogenicK-RASIs Required to Maintain Changes in Cytoskeletal Organization, Adhesion, and Motility in Colon Cancer Cells.
65:1244-1250.
2005
-
Correction.
64:8794-8794.
2004
-
Alterations in Vascular Gene Expression in Invasive Breast Carcinoma.
64:7857-7866.
2004
-
The Phosphoprotein StarD10 Is Overexpressed in Breast Cancer and Cooperates with ErbB Receptors in Cellular Transformation.
64:3538-3544.
2004
-
Gene Expression Profiling-Based Prediction of Response of Colon Carcinoma Cells to 5-Fluorouracil and Camptothecin.
63:8791-8812.
2003
-
TR3/Nur77 in colon cancer cell apoptosis.
63:5401-5407.
2003
-
The direct mapping of the uptake of platinum anticancer agents in individual human ovarian adenocarcinoma cells using a hard x-ray microprobe.
63:1776-1779.
2003
-
AACR special meeting in cancer research: colon cancer--genetics to prevention.
62:6779-6783.
2002
-
A gene expression profile that defines colon cell maturation in vitro.
62:4791-4804.
2002
-
Molecular basis for the synergistic interaction of Adriamycin with the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate (AN-9).
61:8194-8202.
2001
-
p21WAF1/cip1 is an important determinant of intestinal cell response to sulindac in vitro and in vivo.
61:6297-6302.
2001
-
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
61:5349-5354.
2001
-
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.
61:5355-5361.
2001
-
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-GD3 ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
61:4474-4482.
2001
-
Down-regulation of β-catenin TCF signaling is linked to colonic epithelial cell differentiation.
61:3465-3471.
2001
-
Nitric oxide synthase II gene disruption: Implications for tumor growth and vascular endothelial growth factor production.
61:3182-3187.
2001
-
Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor.
61:594-601.
2001
-
Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function.
60:6818-6821.
2000
-
Dissociation of staurosporine-induced apoptosis from G2-M arrest in SW620 human colonic carcinoma cells: Initiation of the apoptotic cascade is associated with elevation of the mitochondrial membrane potential (Δψ(m)).
60:6704-6713.
2000
-
In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3s193) in MCF-7 xenografted BALB/c nude mice.
60:4804-4811.
2000
-
Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: Comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.
60:4561-4572.
2000
-
Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
60:3254-3261.
2000
-
c-myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression.
58:5168-5175.
1998
-
Methylation of the BRCA1 gene in sporadic breast cancer.
57:3347-3350.
1997
-
Transformation of Astrocytes in Transgenic Mice Expressing SV40 T Antigen under the Transcriptional Control of the Glial Fibrillary Acidic Protein Promoter.
55:4302-4310.
1995
-
Inhibition of Angiogenesis by the Matrix Metalloprotease Inhibitor N-[2R-2-(Hydroxamidocarbonymethyl)-4-methylpentanoyl)-L-tryptophan Methylamide.
54:4715-4718.
1994
-
Immunobead-PCR: A Technique for the Detection of Circulating Tumor Cells Using Immunomagnetic Beads and the Polymerase Chain Reaction.
53:3455-3458.
1993
-
THERMOTOLERANCE IN THE ABSENCE OF INDUCED HEAT-SHOCK PROTEINS IN A MURINE LYMPHOMA.
52:2854-2861.
1992
-
LOSS OF THE INTRINSIC HEAT-RESISTANCE OF HUMAN-CELLS AND CHANGES IN MR 70,000 HEAT-SHOCK PROTEIN EXPRESSION IN HUMAN X HAMSTER HYBRIDS.
51:2636-2641.
1991
-
erba-related sequence coding for dna-binding hormone receptor localized to chromosome 3p21-3p25 and deleted in small cell lung carcinoma.
48:682-685.
1988
-
Effects of Sodium Butyrate on the Synthesis and Methylation of DNA in Normal Cells and Their Transformed Counterparts.
46:713-716.
1986
-
Measurements of drinking patterns in the general population and possible applications in studies of the role of alcohol in cancer.
39:2830-2833.
1979
-
MEASUREMENTS OF DRINKING PATTERNS IN THE GENERAL-POPULATION AND POSSIBLE APPLICATIONS IN STUDIES OF THE ROLE OF ALCOHOL IN CANCER.
39:2830-2833.
1979
-
Abstract 2962: LRH-1 expression in breast cancer tissue and its association with phenotype and DNA methylation [Abstract]
2015
-
Abstract 76: Liver receptor homologue-1 increases incidence of DMBA-induced mammary tumors
2014
-
The HDAC inhibitory prodrug AN-7 reduces the toxicity of doxorubicin, anti-Her2 and radiation while augmenting their anticancer efficacy [Abstrat]
2011
-
Cellular responses to doxorubicin-DNA adducts. Is cytotoxicity independent of p53 status?
2009
-
DNA methyltransferases drive gastric cancer growth and present a therapy target for gastric cancer.
2020
-
Abstract GS2-03: The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer
2020
-
Abstract P3-01-10: Ndrg1-egfr axis in inflammatory breast cancer tumorigenesis and brain metastasis
2020
-
Abstract 155: Cysteine-rich secretory protein 3 expression leads to invasive prostate cancer by modulating cell motility
2019
-
Abstract 2492: BRAF inhibitors synergize with BH3 mimetics to induce apoptosis inBRAFmutant colorectal cancer cells
2019
-
Abstract 456: Circulating tumor cells and cfDNA changes during radiotherapy in patients with head and neck cancer
2019
-
Abstract 823: A case-control study of constitutionalBRCA1methylation in a mammographically screened cohort
2019
-
Abstract 840: Identification of novel colorectal tumor suppressor genes through genome-wide promoter hypermethylation analysis
2019
-
Abstract CT063: Preliminary findings of a Phase I safety and bioimaging trial of KB004 (ifabotuzumab) in patients with glioblastoma
2019
-
Abstract CT167: A Phase Ib study to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors
2019
-
Abstract P1-19-02: Innovation in diagnosis and treatment of brain metastases using multifunctional nanomedicines
2019
-
Abstract P5-08-05: The interplay between stromal density, epithelial mesenchymal transition and chemoresistance in breast cancer
2019
-
Characterization of high TIL breast cancers reveals a prognostic and functionally distinct tissue-resident memory subpopulation
2019
-
Long-term exposure (LTE) to Tislelizumab, an investigational anti-PD-1 antibody, in a first-in-human Phase I study
2019
-
Repurposing bazedoxifene to suppress gastrointestinal cancer growth
2019
-
Targeting the myeloid-cell specific SRC-kinase HCK improves anti-tumor immunity
2019
-
Abstract 2671: 17beta-hydroxywithanolides inhibit the proliferation of castration-resistant prostate cancer cells by reducing levels of cFLIP
2018
-
Abstract 5885: Loss of RAD51C promoter hypermethylation confers PARP inhibitor resistance
2018
-
Abstract LB-183: Investigating the role of polarity protein, SCRIB, in hematopoiesis
2018
-
BMP4 suppresses the progression of breast cancer through altered expression of metastasis regulating genes
2018
-
Classification of molecular subtypes of triple-negative breast cancer cell lines using two models
2018
-
EphA2: An emerging target in triple-negative breast cancer
2018
-
A novel approach to overcome resistance to HER2 targeted therapy in a new syngeneic model of breast cancer brain metastasis
2018
-
ABT-806-derived antibody-drug conjugates (ADCs) inhibit growth of malignant mesothelioma in vivo
2018
-
Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort
2018
-
Development of small-molecule mTORC1 radiotracers for evaluation of targeted therapy resistance using PET
2018
-
Exploring the germ-line contribution to exceptional response to PD-1/PD-L1 inhibition in patients with metastatic non-small-cell lung cancer by whole genome sequencing
2018
-
IL-11 as a therapeutic target to treat colorectal cancer
2018
-
Acquired chemotherapeutic drug resistance in colorectal cancer is regulated by epithelial-to-mesenchymal transition and altered cellular pathways
2017
-
Double somatic mutations as a cause of tumor mismatch repair-deficiency in population-based colorectal and endometrial cancer with Lynch-like syndrome
2017
-
Dual role of p120ctn in cancer: epithelial vs mesenchymal
2017
-
Abstract P1-05-03: Predictive value of de novo and induced epithelial-mesenchymal transition in locally advanced breast cancer treated with neoadjuvant chemotherapy
2016
-
Abstract B04: A role for EphA3 in angiogenesis, in vivo and in vitro exploration
2016
-
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma
2016
-
Abstract 1078: TGF-β and TNF-α activate gene transcription programs associated with poor breast cancer prognosis
2015
-
Abstract 3543: Ligand-directed and transcription-based molecular imaging and treatment of cancer
2015
-
Phase I safety and biodistribution study of 124I-PEG-AVP0458 diabody in patients with TAG-72 positive ovarian and prostate cancer
2015
-
Abstract 2058: RHOA inactivation enhances Wnt signaling and promotes colorectal cancer
2015
-
Excessive activation of the Src-kinase HCK in the tumor stroma promotes progression of solid tumors
2015
-
Phase I studies of a selective cMet inhibitor AZD6094 (HMPL504/volitinib) in patients with advanced solid tumors
2015
-
Abstract 2015: Thrombospondin-1 is a targetable marker of invasive, mesenchymal- like melanoma cells
2014
-
Abstract 2339: Transcriptional basis for loss of cellular differentiation in colon cancer
2014
-
Abstract 2835: Telomere length: A novel biomarker for anti-EGFR therapy in colorectal cancer
2014
-
Abstract 290: Constitutional BRCA1 methylation is a major predisposition factor for high-grade serous ovarian cancer
2014
-
Abstract 383: Is loss of MGMT a therapeutic target in lung cancer
2014
-
Abstract 5112: Histone deacetylase and proteasome inhibitors synergistically induce apoptosis in colon cancer, multiple myeloma and CTCL cells through induction of the immediate early genes ATF3 and JUN
2014
-
Abstract 5172: Whole exome mutation landscape of 70 commonly used colorectal cancer cell lines
2014
-
Estrogen receptor alpha drives proliferation of prostate cancer through PI3K and MAPK signaling
2014
-
Mobilization of tumor cells into the circulation during radiation therapy for lung cancer
2014
-
Receptor occupancy and tumor penetration by antibodies, peptides, and antibody fragments: Molecular simulation of imaging assessment
2014
-
The SMAC-mimetic birinapant regulates autocrine TNF production by caspase-8:RIPK1 complex via p38MAPK pathway
2014
-
Abstract P6-12-11: Celecoxib inhibits the growth of IBC tumors by suppressing the regulation of cancer stem-like cells by nodal
2013
-
Excessive Wnt activity is insufficient for intestinal tumor growth or regeneration without gp130/Jak2/Stat3 signaling.
2013
-
Targeting BCL-2 with the BH3 mimetic ABT-199 in ER-positive breast cancer
2013
-
Abstract 1486: The contribution of stromal caveolin-1 to breast cancer metastasis
2012
-
Abstract 2903: Therapeutic targeting of leukemia and lymphoma with a neuropilin-1 binding pro-apoptotic peptide
2012
-
Defining the role of the cellular polarity regulator Scrib in epithelial tumorigenesis
2012
-
Abstract 1690: Definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents
2011
-
Abstract 2629: Sustained immediate-early gene induction is linked to histone deacetylase inhibitor-induced apoptosis in multiple tumour types
2011
-
Abstract 5318: Optimizing pharmacokinetics and targeting properties of recombinant anti-Lewis Y antibody hu3S193 in A431 tumor-bearing mice
2011
-
Abstract 636: C-Met antibodies with distinctive characteristics including induction of receptor degradation without activation and tumor specificity
2011
-
Abstract 3108: Functional delineation of structural domains in Yorkie/Yes-associated protein
2010
-
The Role of microRNA Genes in Breast Cancer Progression and Metastasis.
2009
-
An integrated geneome-wide profiling strategy for the identification of potential epigenetically regulated loci in colon cancer.
2009
-
Aspirin inhibits camptothecin-induced p21(CIP1) protein levels in breast cancer cells: implications for chemotherapy
2009
-
Contribution of specific Inhibitor of Apoptosis Proteins in distinct apoptotic pathways
2009
-
Homology modeling based site-directed mutagenesis of anti-Le(y) antibody hu3S193 Fc:FcRn interactions
2009
-
Humoral immune responses in patients vaccinated with HER2 protein complexed with a novel antigen delivery system of cholesteryl pullulan(CHP-HER2)
2006
-
Inhibition of solid tumor growth by intravenous administration of cG250-TNF immunocytokine
2006
-
The synergistic interaction of mitoxantrone and herceptin
2006
-
Transduction of TNF-related apoptosis inducing ligand (TRAIL) into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo
2006
-
AACR special meeting in cancer research: Colon cancer-genetics to prevention
2002
-
Insights from Bcl-2 and Myc: Malignancy Involves Abrogation of Apoptosis as well as Sustained Proliferation
1999
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)